A new type of pill manufacturing technology could produce a material that helps diabetics to administer insulin orally. The substance, derived from the shells of a certain type of shrimp, is being developed in Taiwan .
According to scientists at the National Tsing Hua University, the shell could protect a drug from stomach acid, a traditional problem for oral insulin delivery. The results were published in the Biomacromolecules journal, and reported by the BBC.
The shell spheres are made of a substance called chitosa, a naturally occurring compound from shrimp shells. Insulin can be placed inside these spheres, which then theoretically deliver the drug into the bloodstream. Although initial tests were effective, the dosage required was far higher than a diabetic would usually need.
In order for the technology to be widely employed, further clinical trials are a necessity.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…